Article
Alteration in lymphocyte phenotype associated with administration of adjuvant levamisole and 5-fluorouracil.
Cancer immunology, immunotherapy : CII - 1 Jun 1994
Holcombe R F, Stewart R M, Betzing K W, Kannan K
Abstract excerpt
Levamisole (LMS) and 5-fluorouracil (5FU) administered adjuvantly are effective in reducing the relapse rate following surgical resection of Duke's stage C colon carcinoma. It has been postulated that LMS acts to stimulate the immune system and that this is one mechanism through which this drug e...
Topics
- Antigens, CD
- Antigens, Differentiation, T-Lymphocyte
- CD56 Antigen
- Chemotherapy, Adjuvant
- Colonic Neoplasms
- Fluorouracil
- Humans
- Killer Cells, Natural
- Levamisole
- Lymphocytes
- Phenotype
- Receptors, Interleukin-2